Stockreport

INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult [Yahoo! Finance]

INmune Bio Inc. - Common stock  (INMB) 
PDF Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today [Read more]